While Alnylam Pharmaceuticals Inc has overperformed by 4.33%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ALNY rose by 74.02%, with highs and lows ranging from $304.39 to $141.98, whereas the simple moving average jumped by 3.76% in the last 200 days.
On March 31, 2025, Redburn Atlantic started tracking Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) recommending Buy. A report published by JP Morgan on March 24, 2025, Upgraded its rating to ‘Overweight’ for ALNY. Goldman August 16, 2024d its ‘Neutral’ rating to ‘Buy’ for ALNY, as published in its report on August 16, 2024. Goldman’s report from February 16, 2024 suggests a price prediction of $173 for ALNY shares, giving the stock a ‘Neutral’ rating. Wolfe Research also rated the stock as ‘Peer Perform’.
Analysis of Alnylam Pharmaceuticals Inc (ALNY)
Further, the quarter-over-quarter increase in sales is 34.90%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Alnylam Pharmaceuticals Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. Taking into account the quick ratio of the company, currently set at 2.71, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and ALNY is recording an average volume of 791.08K. On a monthly basis, the volatility of the stock is set at 4.78%, whereas on a weekly basis, it is put at 5.16%, with a loss of -0.88% over the past seven days. Furthermore, long-term investors anticipate a median target price of $319.71, showing growth from the present price of $266.83, which can serve as yet another indication of whether ALNY is worth investing in or should be passed over.
How Do You Analyze Alnylam Pharmaceuticals Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 4.40%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 95.02% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
ALNY shares are owned by institutional investors to the tune of 95.02% at present.
